- Home
- ORC vs HUMA Comparison
ORC vs HUMA Comparison
Compare ORC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- HUMA
- Stock Information
- Founded
- ORC 2010
- HUMA 2004
- Country
- ORC United States
- HUMA United States
- Employees
- ORC N/A
- HUMA N/A
- Industry
- ORC Real Estate Investment Trusts
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- HUMA Health Care
- Exchange
- ORC Nasdaq
- HUMA Nasdaq
- Market Cap
- ORC 623.6M
- HUMA 584.8M
- IPO Year
- ORC 2013
- HUMA N/A
- Fundamental
- Price
- ORC $7.93
- HUMA $4.61
- Analyst Decision
- ORC Buy
- HUMA Strong Buy
- Analyst Count
- ORC 3
- HUMA 7
- Target Price
- ORC $9.50
- HUMA $13.43
- AVG Volume (30 Days)
- ORC 2.3M
- HUMA 3.9M
- Earning Date
- ORC 01-30-2025
- HUMA 03-21-2025
- Dividend Yield
- ORC 18.16%
- HUMA N/A
- EPS Growth
- ORC N/A
- HUMA N/A
- EPS
- ORC 1.01
- HUMA N/A
- Revenue
- ORC $75,695,000.00
- HUMA N/A
- Revenue This Year
- ORC N/A
- HUMA N/A
- Revenue Next Year
- ORC N/A
- HUMA $5,584.53
- P/E Ratio
- ORC $7.84
- HUMA N/A
- Revenue Growth
- ORC N/A
- HUMA N/A
- 52 Week Low
- ORC $7.41
- HUMA $2.80
- 52 Week High
- ORC $9.08
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- ORC 52.22
- HUMA 50.08
- Support Level
- ORC $7.90
- HUMA $4.41
- Resistance Level
- ORC $8.11
- HUMA $4.67
- Average True Range (ATR)
- ORC 0.13
- HUMA 0.33
- MACD
- ORC 0.02
- HUMA -0.01
- Stochastic Oscillator
- ORC 71.09
- HUMA 45.04
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.